Efficacy and safety of drospirenone 2 mg/17 β-estradiol 1 mg hormone therapy in Korean postmenopausal women (vol 60, pg 213, 2017)

被引：0
|
作者：
Park, Bo Ra [1 ]
Park, Hye Na [1 ]
Jung, Ji Back [1 ]
Lee, Eun Sil [1 ]
Kim, Jeong Sig [1 ]
Choi, Gyu Yeon [1 ]
Lee, Jeong Jae [1 ]
Lee, Im Soon [1 ]
机构：
[1] Soonchunhyang Univ, Coll Med, Dept Obstet & Gynecol, Asan, South Korea
来源：
OBSTETRICS & GYNECOLOGY SCIENCE | 2024年 / 67卷 / 04期
关键词：
D O I：
10.5468/ogs.2017.60.2.213.e1
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [1] Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women
    Lin, S-Q.
    Sun, L-Z.
    Lin, J-F.
    Yang, X.
    Zhang, L-J.
    Qiao, J.
    Wang, Z-H.
    Xu, Y-X.
    Xiong, Z-A.
    Zhou, Y-Z.
    Wang, M-L.
    Zhu, J.
    Chen, S-R.
    Su, H.
    Yang, C-S.
    Wang, S-H.
    Zhang, Y-Z.
    Dong, X-J.
    [J]. CLIMACTERIC, 2011, 14 (04) : 472 - 481
  • [2] Characteristics of nasal epithelial cells in naturally postmenopausal women receiving hormone therapy with 1 mg 17β-estradiol and 2 mg drospirenone:: a prospective study
    Caruso, Salvatore
    Serra, Agostino
    Grillo, Calogero
    Maiolino, Luigi
    Agnello, Carmela
    Di Mari, Lucia
    Cianci, Antonio
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 963 - 966
  • [3] Combined hormone replacement therapy with 1 mg estradiol and 2 mg drospirenone
    Strowitzki, T.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2005, 3 (01): : 55 - 59
  • [4] Effects of hormone therapy containing 2 mg drospirenone and 1 mg 17β-estradiol on postmenopausal exacerbation of Meniere's disease: Preliminary study
    Grillo, Caterina Maria
    Maiolino, Luigi
    Rapisarda, Agnese Maria Chiara
    Caruso, Giuseppe
    Palermo, Gaia
    Caruso, Salvatore
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [5] Prospective study evaluating olfactometric and rhinomanometric outcomes in postmenopausal women on 1 mg 17β-estradiol and 2 mg drospirenone HT
    Caruso, Salvatore
    Serra, Agostino
    Grillo, Calogero
    De Leo, Vincenzo
    Maiolino, Luigi
    Agnello, Carmela
    Cianci, Antonio
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05): : 967 - 972
  • [6] Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: A double-blind, randomized, placebo-controlled, multicenter study
    Lee, B. S.
    Kang, B. M.
    Yoon, B. K.
    Choi, H.
    Park, H. M.
    Kim, J. G.
    [J]. MATURITAS, 2007, 57 (04) : 361 - 369
  • [7] 17β-oestradiol (1 mg) plus drospirenone (2 mg) in hormonal therapy of postmenopausal period
    Stachowiak, Grzegorz
    Pertynski, Tomasz
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (01): : 1 - 4
  • [8] One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women
    Genazzani, A. R.
    Schmelter, T.
    Schaefers, M.
    Gerlinger, C.
    Gude, K.
    [J]. CLIMACTERIC, 2013, 16 (04) : 490 - 498
  • [9] Effects of a new hormone therapy, drospirenone and 17-β-estradiol, in postmenopausal women with hypertension
    White, William B.
    Hanes, Vladimir
    Chauhan, Vijay
    Pitt, Bertram
    [J]. HYPERTENSION, 2006, 48 (02) : 246 - 253
  • [10] Efficacy and safety of a low-dose continuous combined hormone replacement therapy with 0.5 mg 17β-estradiol and 2.5 mg dydrogesterone in subgroups of postmenopausal women with vasomotor symptoms
    Tsiligiannis, Sophia
    Wick-Urban, Bettina C.
    van der Stam, Jan
    Stevenson, John C.
    [J]. MATURITAS, 2020, 139 : 20 - 26
12345